Volume 16, Number 9—September 2010
Dispatch
Increasing Incidence of Mucormycosis in University Hospital, Belgium
Table
Specific annual incidence rate of mucormycosis cases per risk group in a hospital in Belgium, 2000–2008*
Year | Diabetes mellitus | Solid organ transplantation | Hematologic disorder/ malignancy | HSCT |
---|---|---|---|---|
2000 | 0/3,087 | 0/235 | 1/684 | 0/96 |
2001 | 0/3,328 | 0/217 | 2/557 | 1/86 |
2002 | 0/3,319 | 0/207 | 0/650 | 0/87 |
2003 | 0/3,662 | 0/245 | 0/775 | 0/118 |
2004 | 1/3,845 | 0/217 | 0/787 | 0/126 |
2005 | 1/4,121 | 1/191 | 1/853 | 0/103 |
2006 | 0/4,235 | 2/251 | 5/1,061 | 3/91 |
2007 | 0/4,328 | 0/279 | 0/942 | 0/121 |
2008 |
0/4,477 |
1/267 |
3/859 |
1/116 |
p value for the increase in | ||||
No. patients per risk group | <0.01 | 0.12 | <0.01 | 0.19 |
Specific annual incidence rate | 0.81 | 0.11 | 0.91 | 0.55 |
*Values are no. cases per risk group/no. patients admitted per year with that risk factor, unless otherwise indicated. Data for risk group patients based on codes from the International Classification of Diseases, 9th Revision, Clinical Modification, available 2000–2008. HSCT, hematopoietic stem cell transplantation.